Navigation Links
Agilent Technologies Signs Agreement to Supply Target Enrichment System to Ambry Genetics for Exome Sequencing
Date:10/27/2011

more than 100 Mb using eArray, a free online design tool.

About Ambry Genetics

Ambry Genetics is a CAP-accredited and CLIA-certified commercial clinical laboratory with headquarters in Aliso Viejo, Calif. Since the company's inception in 1999, it has become a leader in providing genetic services focused on clinical diagnostics and genomic services, particularly sequencing and array services. Ambry has established a solid reputation for unparalleled service and has been at the forefront of applying new technologies to the clinical molecular diagnostics market and to the advancement of disease research. To learn more about testing and services available through Ambry Genetics, visit www.ambrygen.com.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company's 18,500 employees serve customers in more than 100 countries. Agilent had net revenues of $5.4 billion in fiscal 2010. Information about Agilent is available at www.agilent.com.


'/>"/>
SOURCE Ambry Genetics; Agilent Technologies Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Varian, Inc. Announces Stockholder Approval of Merger Agreement With Agilent Technologies
2. Ambry Genetics Announces Certified Service Provider Status for Agilent Microarrays
3. Life Technologies Launches 3500 Dx Series Genetic Analyzers for In Vitro Diagnostic Use in China
4. Life Technologies Announces Third Quarter 2011 Results
5. Reprints Desk and Deep Web Technologies Announce Agreement to Integrate Research Services
6. Synthetic Genomics Inc. and Plenus, S.A. de C.V. Form New Sustainable Agriculture Company, Agradis, Inc. to Develop and Commercialize Products Using Genomic Technologies
7. Omega Protein Announces Retention of Lipid Technologies, LLC
8. Palatin Technologies to Present at 10th Annual BIO Investor Forum
9. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium at International Contract Services Expo
10. Microring device could aid in future optical technologies
11. Life Technologies Announces Flagship PCR Instrument that Enables Cost-Effective, High-Throughput Screening Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... A new way to produce engineered skin not ... grafting technologies, it also speeds up the healing process, ... the October issue of STEM CELLS Translational Medicine, could ... result from severe burns and chronic wounds. , A ... These wounds heal by contraction, with epithelization (the process ...
(Date:10/25/2014)... LONDON , October 24, 2014 ... CytRx Corporation (NASDAQ: CYTR ), Vertex Pharmaceuticals ... (NASDAQ: ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... on Thursday, October 23, 2014, ended on a positive ...
(Date:10/22/2014)... and BOSTON , Oct. 22, ... a leading global specialty pharmaceutical company, and Rhythm, a ... an exclusive option to acquire Rhythm,s wholly owned subsidiary, ... peptide ghrelin agonist, for the treatment of diabetic gastroparesis ... has completed a successful Phase 2 trial of relamorelin ...
(Date:10/22/2014)... WriteResult, LLC – a premier ... working with a team of researchers from Yale University’s ... Farming Collaborative to provide electronic questionnaire data collection through ... which started in May, aims to evaluate the impact ... exposure to and participation in urban agriculture to impact ...
Breaking Biology Technology:New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 2New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3
... is next weekend's BarCamp Madison , but his long-view ... state's first national technology unconference. , ,Wisconsin has the honor ... 23-26 on the Jefferson County fairgrounds. , ,Rheingans, director of ... to draw 5,000 technologists to the 90-acre site, which is ...
... and the Vancouver Island Health Authority (VIHA) ... authority would purchase 48 new ultrasound systems. , ,The ... new clinical workflow and administrative processes. , ,Jac ... result in more precise diagnosis and faster exams, and reduce ...
... of articles on developing start-up companies in the technology or ... , , Madison, Wis. - Your ... workers. As discussed in the previous article, you generally must ... and Medicare taxes, and unemployment taxes on wages ...
Cached Biology Technology:Wisconsin to host technology BarCamp USA 2Wisconsin to host technology BarCamp USA 3Early Stage 7, Part I: Just what is an employee? 2Early Stage 7, Part I: Just what is an employee? 3Early Stage 7, Part I: Just what is an employee? 4Early Stage 7, Part I: Just what is an employee? 5
(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... Melbourne researchers have challenged conventional thinking on how the ... new mechanism for how bowel cancer starts. , The ... maintaining and regenerating the ,crypts, that are a feature ... are involved in bowel cancer development, a controversial finding ... existence. , Using 3D imaging technologies, Dr Chin Wee ...
(Date:10/16/2014)... (October 16, 2014) – Post-menopausal women experienced improvements ... hormone levels or genital bleeding, after 12 weeks ... investigational fermented soy germ-based nutritional supplement previously shown ... a new peer-reviewed pilot study reported in a ... annual scientific meeting. , "These data documented ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Cryptic clues drive new theory of bowel cancer development 2S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2
... humans to plants to the lowliest bacterium use molecules ... an organism,s development, and still others are used to ... California Institute of Technology have now found a rare ... Caenorhabditis elegans that serves a dual purpose, working ...
... L-1 Identity,Solutions, Inc., (NYSE: ID ), ... hold a supplemental conference call for Q&A with ... ended June 30,2008 financial results at 2:00 p.m. ... the initial 11:00 a.m. (ET) call,today were unable ...
... healthy, nutritious plant. The research paper, published with ... Carolina, appeared in the early online edition of the ... week of July 21. "There,s a lot of attention ... principal investigator on the study and one of the authors ...
Cached Biology News:Caltech researchers find dual-use sexual attraction and population-control chemicals in nematodes 2Caltech researchers find dual-use sexual attraction and population-control chemicals in nematodes 3L-1 Identity Solutions to Hold Supplemental Second Quarter 2008 Financial Results Q&A Conference Call at 2:00p.m. (ET) Today 2Dartmouth researchers identify an important gene for a healthy, nutritious plant 2